Beta-2 adrenergic receptor mRNA (ADRB2 mRNA) (ADRB2 mRNA)

Beta-2 adrenergic receptor mRNA (ADRB2 mRNA) is the transcript encoded by the ADRB2 gene (NCBI Gene: 154), serving as the essential template for the synthesis of the Beta-2 adrenergic receptor protein. This protein is a G protein-coupled receptor (GPCR) that plays a vital role in mediating smooth muscle relaxation in the airways and blood vessels (Source: UniProt P07550). While the ADRB2 protein is the classical target for bronchodilators like albuterol, the mRNA itself is a target for experimental RNA-based therapies, including antisense oligonucleotides and siRNAs designed to modulate receptor expression (Source: PubMed PMID 10449236). ADRB2 mRNA levels are also significantly influenced by other drugs; for instance, glucocorticoids are known to increase ADRB2 mRNA transcription, which helps prevent the receptor desensitization often seen with chronic beta-agonist use (Source: StatPearls, Beta 2 Agonists). In clinical research, the quantification of ADRB2 mRNA serves as a biomarker for assessing receptor regulation and the impact of genetic polymorphisms on drug response in respiratory and cardiovascular diseases (Source: PubMed PMID 11752876).

Other names

ADRB2 transcriptB2AR mRNABeta-2 adrenoceptor mRNAADRB2 messenger RNA

Experimental drugs target ADRB2 mRNA through RNA interference (siRNA) or antisense-mediated degradation (ASO), which prevents the translation of the mRNA into the functional Beta-2 adrenergic receptor protein.